n Cardiovascular Journal of South Africa - AstraZeneca's investment in landmark trials in heart failure : drug trends in cardiology
|Article Title||AstraZeneca's investment in landmark trials in heart failure : drug trends in cardiology|
|© Publisher:||Clinics Cardive Publishing|
|Journal||Cardiovascular Journal of South Africa|
|Publication Date||Jan 2002|
|Pages||38 - 40|
Extracted from text ... Heart failure is a common, distressing and disabling illness and is associated with a worse outcome than in many forms of cancer. For many patients, the prognosis is poor: it is estimated that 50% of patients with heart failure will die within five years. It is estimated that up to 50 million of the 1 000 million people (5%) who inhabit the 47 nations which are members of the European Society of Cardiology may have a heart failurerelated problem.1 It is also a severe burden on healthcare resources. The direct costs of heart failure in developed countries are thought to ..
Article metrics loading...